Precigen Analyst Ratings
Precigen Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/10/2023 | 383.87% | HC Wainwright & Co. | → $6 | Reiterates | Buy → Buy |
06/05/2023 | 1029.03% | JMP Securities | → $14 | Reiterates | → Market Outperform |
05/23/2023 | — | JP Morgan | Initiates Coverage On | → Neutral | |
05/11/2023 | 1029.03% | JMP Securities | → $14 | Reiterates | Market Outperform → Market Outperform |
03/07/2023 | 1029.03% | JMP Securities | → $14 | Reiterates | → Market Outperform |
03/07/2023 | 383.87% | HC Wainwright & Co. | → $6 | Reiterates | → Buy |
01/30/2023 | 706.45% | Cantor Fitzgerald | $7 → $10 | Maintains | Overweight |
11/18/2022 | 464.52% | Cantor Fitzgerald | → $7 | Initiates Coverage On | → Overweight |
11/10/2022 | 1029.03% | JMP Securities | $13 → $14 | Maintains | Market Outperform |
08/09/2022 | 383.87% | HC Wainwright & Co. | $10 → $6 | Maintains | Buy |
02/25/2021 | 948.39% | Stifel | → $13 | Initiates Coverage On | → Buy |
02/22/2021 | 1029.03% | Wells Fargo | → $14 | Initiates Coverage On | → Overweight |
12/16/2020 | 706.45% | HC Wainwright & Co. | $8 → $10 | Maintains | Buy |
05/08/2020 | 303.23% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
08/10/2023 | 383.87% | HC Wainwright & Co. | → 6 美元 | 重申 | 購買 → 購買 |
06/05/2023 | 1029.03% | JMP 證券 | → 14 美元 | 重申 | → 市場跑贏大盤 |
05/23/2023 | — | 摩根大通 | 啓動覆蓋開啓 | → 中立 | |
05/11/2023 | 1029.03% | JMP 證券 | → 14 美元 | 重申 | 市場跑贏大盤 → 市場跑贏大盤 |
03/07/2023 | 1029.03% | JMP 證券 | → 14 美元 | 重申 | → 市場跑贏大盤 |
03/07/2023 | 383.87% | HC Wainwright & Co. | → 6 美元 | 重申 | → 購買 |
01/30/2023 | 706.45% | 坎託·菲茨傑拉德 | 7 美元 → 10 美元 | 維護 | 超重 |
11/18/2022 | 464.52% | 坎託·菲茨傑拉德 | → 7 美元 | 啓動覆蓋開啓 | → 超重 |
2022 年 10 月 11 日 | 1029.03% | JMP 證券 | 13 美元 → 14 美元 | 維護 | 市場表現跑贏大盤 |
08/09/2022 | 383.87% | HC Wainwright & Co. | 10 美元 → 6 美元 | 維護 | 購買 |
2021 年 2 月 25 日 | 948.39% | Stifel | → 13 美元 | 啓動覆蓋開啓 | → 購買 |
2021 年 2 月 22 日 | 1029.03% | 富國銀行 | → 14 美元 | 啓動覆蓋開啓 | → 超重 |
2020 年 12 月 16 日 | 706.45% | HC Wainwright & Co. | 8 美元 → 10 美元 | 維護 | 購買 |
05/08/2020 | 303.23% | HC Wainwright & Co. | → 5 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for Precigen (PGEN)?
Precigen (PGEN) 的目標價格是多少?
The latest price target for Precigen (NASDAQ: PGEN) was reported by HC Wainwright & Co. on August 10, 2023. The analyst firm set a price target for $6.00 expecting PGEN to rise to within 12 months (a possible 383.87% upside). 9 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月10日公佈了Precigen(納斯達克股票代碼:PGEN)的最新目標股價。這家分析公司將目標股價定爲6.00美元,預計PGEN將在12個月內升至6.00美元(可能上漲383.87%)。去年有9家分析公司公佈了評級。
What is the most recent analyst rating for Precigen (PGEN)?
分析師對 Precigen (PGEN) 的最新評級是多少?
The latest analyst rating for Precigen (NASDAQ: PGEN) was provided by HC Wainwright & Co., and Precigen reiterated their buy rating.
Precigen(納斯達克股票代碼:PGEN)的最新分析師評級由HC Wainwright & Co. 提供,Precigen 重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Precigen (PGEN)?
Precigen (PGEN) 的下一個分析師評級何時公佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Precigen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Precigen was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.
分析師在進行了廣泛的研究(包括瀏覽公開財務報表、與Precigen的高管和客戶交談以及聽取業績電話會議)後得出了股票評級。大多數分析師每三個月進行一次評級,因此每家公司每年應該獲得4個評級。Precigen的最後一次評級是在2023年8月10日提交的,因此您應該預計下一個評級將在2024年8月10日左右公佈。
Is the Analyst Rating Precigen (PGEN) correct?
分析師對 Precigen (PGEN) 的評級是否正確?
While ratings are subjective and will change, the latest Precigen (PGEN) rating was a reiterated with a price target of $0.00 to $6.00. The current price Precigen (PGEN) is trading at is $1.24, which is within the analyst's predicted range.
雖然評級是主觀的,會發生變化,但最新的Precigen(PGEN)評級得到了重申,目標股價爲0.00美元至6.00美元。Precigen(PGEN)目前的交易價格爲1.24美元,在分析師的預測區間內。
譯文內容由第三人軟體翻譯。